The CHARM program consisted of 3 component trials, each comparing candesartan with placebo in a distinct population of patients with symptomatic heart failure [9]: CHARM-Alternative: patients with ...

A substudy of the CHARM trial (see Trial Glossary below for expansion of all trial names mentioned in this article) has shown that the angiotensin receptor blocker (ARB) candesartan reduces the risk ...

A person with advanced heart failure can look stable at a routine clinic visit. Their vitals may not alarm anyone.

Nationally, there has been a rise in the number of children and adolescents with congenital and acquired heart disease ...

Please provide your email address to receive an email when new articles are posted on . CAD was significantly prognostic of all-cause mortality in patients with heart failure. Mortality risk was ...

Applying artificial intelligence techniques to cardiac ultrasound data may make it easier to identify patients with advanced heart failure, a new study has found. The study—led by investigators at ...

Researchers have trained an artificial intelligence model to extract warning signs of advanced heart failure from routine ...

Late-stage failure of the left side of the heart is an often-fatal condition affecting hundreds of thousands of people in the U.S. alone. A mechanical heart pump can be a lifesaving intervention for ...

Noninvasive liver fibrosis scores are associated with increased heart failure risk, with FIB-4, NFS, and APRI showing significant correlations. Higher scores correlate with increased heart failure ...

A new study indicated that excess fat stored around the waist or visceral fat was more strongly associated with heart failure ...

A systematic review and dose-response meta-analysis of seven prospective cohorts found that drinking 2 to 4 cups of coffee a ...